Latest Headlines
-
Revvity Launches Signals LabGistics Solution To Connect And Orchestrate Scientific Workflows
10/20/2026
Revvity, Inc., announced that its Revvity Signals Software business is launching the Signals LabGistics solution, an AI-first, scientific workflow orchestration solution designed to connect and coordinate processes, workflows, and tasks from discovery to manufacturing.
-
Hologic And Inpeco Announce Co-Marketing Partnership To Advance Molecular Laboratory Automation
10/20/2026
Hologic, Inc., a global leader in women’s health and diagnostics, and Inpeco S.A., the global leader in Total Laboratory Automation, today announced they have signed a co-marketing partnership for Inpeco’s automation solution FlexLab X and Hologic’s Panther System in Europe.
-
Metabolic Supply Group Brings Lab Testing And Physician Oversight To Metabolic And Peptide Care
10/19/2026
Metabolic Supply Group (MSG), the administrative services organization that connects wellness providers to a vetted national network of licensed compounding pharmacies, today announced a partnership with a healthcare infrastructure company whose platform connects providers to a nationwide network of CLIA-certified laboratories.
-
Novel Biopump Delivers Ultra-Low Shear Flow
10/19/2026
VentriLabs, a subsidiary of Biotech Fluidics, has developed the DuaFLO BioPump, a novel pumping system engineered for upstream and downstream bioprocessing.
-
Biodesix Adds Digital Diagnostics To Lung Pipeline, Creating New Growth Platform Combining Blood And Imaging Biomarkers
10/19/2026
Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics solutions company, today announced the addition of Digital Diagnostics to its Lung Diagnostics strategy, establishing the foundation for a multimodal diagnostic platform that combines blood-based biomarkers, imaging biomarkers, and artificial intelligence.
-
Semax Peptide Introduced By Kylo Peptides For Laboratory Use
10/16/2026
Kylo Peptides has added Semax [https://kylopeptides.com/product/semax/] to its research catalog this week.
-
EVIDENT Expands Its Pramana Digital Pathology Portfolio To Support Small And Medium-Sized Labs
10/16/2026
Today, Evident announced the Pramana™ POD whole slide imaging (WSI) scanner, a new benchtop system designed to help laboratories produce trusted images. Built for small and medium-sized laboratories and specialty applications within larger institutions, the scanner helps make digital pathology adoption more accessible.
-
NeoGenomics Expands Indica Labs Partnership To Scale AI-Powered Digital Pathology
10/15/2026
NeoGenomics, Inc., a provider of oncology diagnostic solutions that enable precision medicine across the cancer care continuum, has expanded its partnership with Indica Labs, a global leader in AI-powered digital pathology.
-
Labcorp Enters Into Agreement With OPKO Health To Acquire Select Assets Of BioReference Health
10/15/2026
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK), a multinational biopharmaceutical company, announced today that they have entered into an agreement for Labcorp to acquire select assets of BioReference Health, LLC, a wholly owned subsidiary of OPKO Health.
-
Delve Bio Expands Metagenomic Infectious Disease Testing With Launch Of Delve Detect Plasma At IDWeek 2026
10/14/2026
Delve Bio, Inc., a UCSF spin-out and pioneer in metagenomic next-generation sequencing (mNGS) for infectious diseases, today announced the launch of Delve Detect Plasma, expanding its testing menu beyond cerebrospinal fluid (CSF) to enable more comprehensive pathogen detection from a single blood sample.